Skip to main content

Changes in Physiological Concentrations of Blood Phenylalanine Produce Changes in Sensitive Parameters of Human Brain Function

  • Chapter
Dietary Phenylalanine and Brain Function

Abstract

We previously demonstrated that increases of 1.0 mM in blood phenylalanine (Phe) decreased plasma L-DOPA, slowed brain electrical discharge, and prolonged performance on neuropsychological tests of higher integrative function. In this study, we evaluate the sensitivity of these tests of brain function during moderate elevation of plasma Phe. Six adult heterozygotes for phenylketonuria (PKU) and one homozygous normal volunteer were studied using a double-blind, double-crossover protocol of four 2-week intervals. Volunteers ingested a constant diet of 50 to 60 mg of Phe per kg per day supplemented by either 100 mg of Phe per kg per day or placebo. On the final two days of each study interval, the following parameters of brain function were evaluated: mean power frequency (MPF) of the EEG, plasma L-DOPA concentration, and cognitive function. The results indicate that plasma Phe rose in both heterozygotes and control during supplemental Phe ingestion from a mean of 99 ± 20 µM to 239 ± 166 µM. There was a wide range of interindividual variation with changes of plasma Phe between 7 µM and 403 µM, thus enabling evaluation of relative sensitivities among these parameters of brain function. Changes in EEG, L-DOPA, and cognitive function were all inversely related to plasma Phe changes between 330 and 403 µM. The MPF was the most sensitive of these parameters with changes seen with as low as 7 µM change in Phe. These changes were seen in the high-frequency α-band (8 to 12 cps) and gave a slope such that for every 100 µM change in plasma Phe, there was a 0.125-cps change in the inverse direction for brain wave function. This slope was similar to that seen in previous studies at changes in Phe concentration between 600 and 2400 µM. The plasma Phe concentrations used in these studies are attained by the chronic ingestion of 34 mg of aspartame per kg per day.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Dyer, F.N. (1973). The Stroop phenomenon and its use in the study of perceptual, cognitive and response processes. Memory and Cognition 1:106–120.

    Article  Google Scholar 

  • Ellis, N. (1985). Tests of cognitive impairment (TCI). University of Alabama, Tuscaloosa, Alabama.

    Google Scholar 

  • Griffin, R.F., and Elsas, L.J. (1975). Classic phenylketonuria diagnosis through heterozygote detection. J. Pediatr. 86:572–577.

    Google Scholar 

  • Harper, A.E. (1984). Phenylalanine metabolism. In Stegink, L.D., and Filer, L.J. (eds.), Aspartame: physiology and biochemistry. New York: Marcel Dekker, pp. 77–111.

    Google Scholar 

  • Krause, W., Halminski, M., McDonald, L., Dembure, P., Salvo, R., Freides, D., and Elsas, L. (1985). Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. J. Clin. Invest. 75:40–48.

    Article  PubMed  CAS  Google Scholar 

  • Krause, W., Epstein, C., Averbook, A., Dembure, P., and Elsas, L. (1986). Phenylalanine alters the mean power frequency of electroencephalograms and plasma L-DOPA in treated patients with phenylketonuria. Pediatr. Res. 20:1112–1116.

    Article  PubMed  CAS  Google Scholar 

  • Pardridge, W. (1986). Potential effects of the dipeptide sweetener aspartame on the brain. In Wurtman, R.J., and Wurtman, J.J. (eds.), Nutrition and the brain. New York: Raven Press, pp. 199–241.

    Google Scholar 

  • Trotter, J., Epstein, C., Dembure, P., and Elsas, L. (1987). The effect of moderately elevated plasma phenylalanine on brain function. Clin. Res. 35:61A.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Birkhäuser Boston

About this chapter

Cite this chapter

Elsas, L.J., Trotter, J.F. (1988). Changes in Physiological Concentrations of Blood Phenylalanine Produce Changes in Sensitive Parameters of Human Brain Function. In: Wurtman, R.J., Ritter-Walker, E. (eds) Dietary Phenylalanine and Brain Function. Birkhäuser Boston. https://doi.org/10.1007/978-1-4615-9821-3_22

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-9821-3_22

  • Publisher Name: Birkhäuser Boston

  • Print ISBN: 978-1-4615-9823-7

  • Online ISBN: 978-1-4615-9821-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics